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Abstract
Background: Excitatory interneurons account for the majority of neurons in laminae I–III, but their functions are poorly
understood. Several neurochemical markers are largely restricted to excitatory interneuron populations, but we have limited
knowledge about the size of these populations or their overlap. The present study was designed to investigate this issue by
quantifying the neuronal populations that express somatostatin (SST), neurokinin B (NKB), neurotensin, gastrin-releasing
peptide (GRP) and the g isoform of protein kinase C (PKCg), and assessing the extent to which they overlapped. Since it has
been reported that calretinin- and SST-expressing cells have different functions, we also looked for co-localisation of
calretinin and SST.
Results: SST, preprotachykinin B (PPTB, the precursor of NKB), neurotensin, PKCg or calretinin were detected with
antibodies, while cells expressing GRP were identified in a mouse line (GRP-EGFP) in which enhanced green fluorescent
protein (EGFP) was expressed under control of the GRP promoter. We found that SST-, neurotensin-, PPTB- and PKCg-
expressing cells accounted for 44%, 7%, 12% and 21% of the neurons in laminae I–II, and 16%, 8%, 4% and 14% of those in
lamina III, respectively. GRP-EGFP cells made up 11% of the neuronal population in laminae I–II. The neurotensin, PPTB and
GRP-EGFP populations showed very limited overlap, and we estimate that between them they account for 40% of the
excitatory interneurons in laminae I–II. SSTwhich is expressed by 60% of excitatory interneurons in this region, was found
in each of these populations, as well as in cells that did not express any of the other peptides. Neurotensin and PPTB were
often found in cells with PKCg, and between them, constituted around 60% of the PKCg cells. Surprisingly, we found
extensive co-localisation of SST and calretinin.
Conclusions: These results suggest that cells expressing neurotensin, NKB or GRP form largely non-overlapping sets that
are likely to correspond to functional populations. In contrast, SST is widely expressed by excitatory interneurons that are
likely to be functionally heterogeneous.
Keywords
Dorsal horn, somatostatin, neurotensin, neurokinin B, gastrin-releasing peptide
Date received: 12 November 2015; accepted: 10 December 2015
Background
Defining the neuronal circuitry within the dorsal horn of
the spinal cord is important because this region contains
the first synapse in the pain and itch pathways and is a site
at which significant modulation of nociceptive, and prur-
itoceptive transmission can occur.1–8 A crucial factor that
has limited our understanding of this circuitry is the com-
plex organisation of interneurons, which account for the
great majority of neurons in laminae I–III.2,7,9,10
Interneurons in these laminae are diverse in terms of
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their structure and function.11–20 They can be divided into
two main groups: inhibitory (GABAergic and/or glyci-
nergic) and excitatory (glutamatergic) neurons.2 There
have been several attempts to define functional popula-
tions among these cells, but although combined electro-
physiological and morphological approaches have
demonstrated that certain interneuron classes can be
recognised in each lamina,11,19,20 these have failed to pro-
vide a comprehensive classification scheme that can be
used as a basis for defining the neuronal circuitry of the
region.
Laminae I–III contain a diverse array of neurochem-
ical markers, including various neuropeptides and their
receptors, together with other proteins, such as calcium-
binding proteins, the g isoform of protein kinase C
(PKCg) and neuronal nitric oxide synthase
(nNOS).1,2,21 Each of these peptides/proteins is expressed
by specific populations of neurons: in some cases, they
are restricted to either excitatory or inhibitory cells,
while in others, they can be found among both types.
Recent studies have defined four largely non-overlapping
populations among the inhibitory interneurons, based on
expression of neuropeptide Y, parvalbumin, nNOS or
galanin/dynorphin.22–24 Between them, these popula-
tions account for over half of the inhibitory interneurons
in laminae I–II, and they show distinct developmental
and functional properties.24–28
Much less is known about the organisation of excita-
tory interneurons, although it has been demonstrated
that some of those in lamina II can be assigned to one
of two morphological classes: vertical and radial
cells.11,14,15,17,29,30 Several neurochemical markers have
been shown to be mainly or completely restricted to
the excitatory interneurons, including the neuropeptides
somatostatin (SST), neurotensin, neurokinin B (NKB)
and gastrin-releasing peptide (GRP), the calcium-bind-
ing proteins calbindin and calretinin and PKCg.12,28,31–43
However, our knowledge about the pattern of co-locali-
sation of these different markers is incomplete. In the rat,
it has been reported that there is overlap between SST
and NKB, but that neither of these are co-expressed with
neurotensin, and that all three peptides are found in
some PKCg-immunoreactive neurons.32,35,43 In the
mouse, GRP is thought to be expressed in cells with
SST, but not those with NKB and shows limited overlap
with PKCg.36,44
Recent studies have suggested specific roles for certain
neurochemically defined populations of excitatory inter-
neurons in pain mechanisms. For example, it has been
proposed that the PKCg cells are involved in transmis-
sion of input from myelinated low threshold mechano-
receptors to lamina I projection neurons, thus
contributing to tactile allodynia in chronic pain
states.45 In addition, Duan et al.25 reported that ablating
the SST-expressing cells (but not NKB or calretinin
neurons) resulted in loss of mechanical pain. It is, there-
fore, important to define the patterns of expression of
these neurochemical markers among the excitatory inter-
neurons, as this may provide evidence for specific func-
tional populations, as was shown to be the case for the
inhibitory interneurons.22 The main aims of the present
study were to quantify the neurons that express SST,
NKB, neurotensin, GRP and PKCg in the mouse,
assess the extent of overlap between these populations
and determine the proportion of excitatory interneurons
that they account for. Because of the reported difference
between the effects of ablating SST- and calretinin-
expressing cells,25 we also tested the extent to which
SST and calretinin were co-localised.
Methods
All animal experiments were approved by the Ethical
Review Process Applications Panel of the University of
Glasgow and were performed in accordance with the
European Community directive 86/609/EC and the UK
Animals (Scientific Procedures) Act 1986.
Animals and general features of tissue processing
Five adult wild-type male C57Bl/6 mice (24-33 g) and 6
Tg(GRP-EGFP) mice of either sex (21–31 g)
(GENSAT)36,46 were deeply anaesthetised with pento-
barbitone (30mg i.p.) and perfused through the left ven-
tricle with fixative that contained 4% freshly
depolymerised formaldehyde in 0.1M PB. Mid-lumbar
spinal cord segments (L4 and L5) were dissected out and
stored for 2–4 h in the same fixative. They were then cut
into transverse sections with a vibrating-blade micro-
tome and immersed in 50% ethanol for 30min to
enhance antibody penetration. Multiple-labelling
immunofluorescence staining was performed as
described previously.27,36,47 Briefly, sections were incu-
bated for 1–3 days at 4C in primary antibodies diluted
in phosphate-buffered saline (PBS) that contained 0.3M
NaCl and 0.3% Triton X-100. They were then incubated
overnight in species-specific secondary antibodies that
were raised in donkey and conjugated to Alexa 488,
Alexa 647, Rhodamine Red, Pacific Blue or biotin
(Jackson Immunoresearch, West Grove, PA, USA). All
secondary antibodies were diluted 1:500 (in the same
diluent), apart from those conjugated to Pacific Blue or
Rhodamine Red, which were diluted 1:200 and 1:100,
respectively. Biotinylated secondary antibodies were
detected either with Pacific Blue conjugated to avidin
(1:1000; Life Technologies, Paisley, UK), or with a tyr-
amide signal amplification (TSA) method (TSA kit tetra-
methylrhodamine NL702, PerkinElmer Life Sciences,
Boston, MA, USA). The TSA reaction was used
to detect the antibody against preprotachykinin
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B (PPTB, the precursor for NKB), as this method can
reveal the cell bodies of neurons that express NKB.35,48
The GRP-EGFP mouse was used to allow identifica-
tion of presumed GRP-expressing cells in the superficial
dorsal horn because the level of GRP in cell bodies of
these neurons is below the limit of detection with
immunocytochemistry.44 Solorzano et al.44 have demon-
strated that 93% of the lamina II EGFP-positive cells in
this mouse contain mRNA for GRP.
Quantification of populations expressing
PKC and neuropeptides
To determine the proportion of neurons in each of lami-
nae I–III that expressed PKCg, SST, neurotensin, or
NKB, sections from three wild-type animals were reacted
with a mixture of primary antibodies, consisting of anti-
PKCg (guinea pig or rabbit antibodies) and NeuN,
together with antibody against one of the following:
SST, neurotensin (rabbit or rat antibodies) or PPTB.
Following the immunocytochemical reaction, the sec-
tions were incubated in DAPI to label cell nuclei. To
determine the proportion of neurons in each lamina
that were EGFP-positive in the GRP-EGFP mice, sec-
tions from three of these animals were reacted with anti-
bodies against EGFP, PKCg (guinea pig) and NeuN,
followed by fluorescent secondary antibodies and
nuclear staining with DAPI.
In each case, a modification49 of the optical disector
method50 was used to obtain an unbiased sample of neu-
rons in laminae I–II and lamina III. For each antibody
combination, two sections were selected before immu-
nostaining for the corresponding peptide was viewed.
These were scanned with a Zeiss LSM710 confocal
microscope equipped with Argon multi-line, 405 nm
diode, 561 nm solid state and 633 nm HeNe lasers and
a spectral detection system. Confocal image stacks were
acquired by scanning through a 40 oil-immersion lens
(numerical aperture 1.3) with the aperture set to 1 Airy
unit, and in each case, these consisted of 30 optical sec-
tions at 1 mm z-spacing. The confocal image stacks were
analysed with Neurolucida for Confocal software (MBF
Bioscience, Williston, VT, USA) as described previ-
ously.23,51–53 The border between laminae II and III
was defined as the ventral limit of the plexus of PKCg
dendrites that occupies the inner half of lamina II, and
this was added to the Neurolucida drawings. We have
shown that in the rat, the dense plexus of PKCg den-
drites occupies the inner half of lamina III, and that its
ventral limit corresponds closely to the lamina II/III
border defined by dark-field illumination.54 The lamina
III/IV border was identified by the somewhat lower
packing density of neurons in lamina IV.55 Throughout
this study, we grouped laminae I and II together, and we
therefore did not define the lamina I–II border. In each
confocal z-stack, the 15th and 24th optical sections were
taken as the reference and look up sections, and all neur-
onal nuclei (defined by the presence of NeuN and DAPI
staining) that had their bottom surface between these sec-
tions were plotted onto the drawing. In all cases in which
the disector method was used, we carefully examined
staining in all optical sections between the look-up and
reference sections and added the locations of any cells
that were entirely contained between these two sections.49
The channel corresponding to the neuropeptide (SST,
neurotensin or PPTB) or EGFP (in the GRP-EGFP
tissue) was then viewed, and the presence or absence of
staining was recorded for each of the selected neurons.
For the tissue from wild-type mice, the PKCg channel
was then viewed, and all PKCg-immunoreactive neurons
were identified among the sample of selected neurons. The
PKCg analysis was not performed on the GRP-EGFP
tissue because we have previously reported that there is
limited co-localisation between EGFP and PKCg in this
mouse line.36 In this way, we determined the proportions
of neurons in laminae I–II and in lamina III that were
immunoreactive for each of the peptides or PKCg, as
well as the extent of co-localisation of PKCg with SST,
neurotensin and PPTB.
Assessment of co-localisation of the neuropeptides
To determine the extent of overlap between SST, neuro-
tensin and GRP-EGFP populations, sections from three
GRP-EGFP mice were immunoreacted with antibodies
against EGFP, SST, neurotensin (rat antibody) and
NeuN. Two sections from each mouse were selected
and scanned with the confocal microscope as described
above, except that z-stacks through the full thickness of
the section were obtained. The outline of the dorsal horn
was drawn with Neurolucida, and the lamina borders
were identified and plotted as above, except that in this
case, the ventral border of the plexus of SST-immunor-
eactive profiles was used to define the border between
laminae II and III. In analysing sections immunostained
for both SST and PKCg (see above), we had found that
the ventral borders of both PKCg-immunoreactive and
SST-immunoreactive plexuses were in the same location
(Figure 1). The optical disector technique was initially
used to select SST-immunoreactive cells. All SST-immu-
noreactive neurons that had the bottom of their cell
bodies between reference and look-up sections (15th
and 24th optical sections, respectively) were plotted
onto the Neurolucida drawing. In some cases, NeuN
staining extends into proximal dendrites, but these
could be recognised because of their reduced diameter,
compared to the cell bodies from which they originated.
The channels corresponding to neurotensin and EGFP
were then viewed, and the presence or absence of each
type of staining was recorded for each of the selected
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SST-immunoreactive cells. The same z-stacks were then
re-analysed to identify first the neurotensin-immunoreac-
tive and then the EGFP-positive cells. However, because
the neurotensin and GRP-EGFP populations are smaller
than the SST population, we increased the size of the
disector (i.e. the separation between reference and
look-up sections) to between 18 and 30 mm in order to
increase the number of cells sampled. In this way, we
determined the proportion of neurotensin-immunoreac-
tive cells that were SST-immunoreactive and/or EGFP-
positive, and the proportion of EGFP-positive cells that
were SST- and/or neurotensin-immunoreactive.
Co-localisation of SST and PPTB was quantified in
sections from three wild-type mice that had undergone
an immunoreaction with antibodies against SST, PPTB
and NeuN. The selection, scanning and analysis was per-
formed exactly as described earlier, with a 10 mm disector
to select SST-immunoreactive cells, and a 20–25mm dis-
ector to select PPTB-positive cells. Again, we determined
the proportion of SST cells that were PPTB-positive, and
vice versa.
Co-localisation between neurotensin and PPTB was
assessed in sections from three wild-type mice that had
been immunoreacted with antibodies against neurotensin
(rat), PPTB, PKCg (rabbit) and NeuN. The sections
were selected, scanned and analysed as described earlier,
except that the PKCg plexus was used to define the
lamina II/III border and the disector separation was
between 20 and 25 mm. Initially, PPTB-immunoreactive
neurons with the bottom surface of their cell bodies
between reference and look-up section were analysed,
and then the neurotensin channel was viewed and the
proportion of the selected PPTB-immunoreactive cells
that were also neurotensin-immunoreactive was deter-
mined. The sequence was then reversed, and we deter-
mined the proportion of neurotensin-immunoreactive
cells that were also PPTB-immunoreactive.
To look for possible co-localisation of PPTB and
EGFP in the GRP-EGFP mouse, sections from three
of these animals were reacted with antibodies against
EGFP, PPTB, PKCg and NeuN. A single section from
each animal was selected and scanned as described ear-
lier. The lamina II/III border was identified from the
PKCg plexus, and sections were searched for possible
co-localisation between PPTB-immunoreactivity and
EGFP.
Co-localisation of SST and calretinin
This was assessed in sections from three wild-type mice
that were reacted with antibodies against SST, calretinin,
NeuN and then stained with DAPI to reveal cell nuclei.
Sections were selected and scanned as described earlier.
The lamina borders were plotted onto an outline of the
dorsal horn with Neurolucida, and the laminar bound-
aries defined as described previously. Initially, we
selected all SST-immunoreactive neurons in laminae
I–II for which the bottom of the nucleus was located
between the 15th and 24th optical sections, and then
viewed the calretinin channel to determine the propor-
tion that were calretinin-immunoreactive. We then used
the same approach to select calretinin-immunoreactive
neurons and determine the proportion that were SST-
immunoreactive.
Characterisation of antibodies
A list of the sources and dilutions of primary antibodies
used in the study is given in Table 1. The somatostatin
antiserum is reported to show 100% cross-reactivity with
somatostatin-28 and somatostatin-25, but none with
substance P, neuropeptide Y or vasoactive intestinal pep-
tide (manufacturer’s specification), and we have shown
that staining with this antibody is abolished by pre-incu-
bation with 10 mg/ml somatostatin.32 The rabbit anti-
body against neurotensin shows no cross-reactivity
with kinetensin, substance P or bombesin (manufac-
turer’s specification), and staining is blocked by
Table 1. Primary antibodies used in this study.
Antibody Species Catalogue no Dilution Source
Somatostatin Rabbit T-4103 1:1,000 Peninsula
Neurotensin Rabbit IHC7351 1:1,000 Peninsula
Neurotensin Rat 1:1,000 P Ciofi
PPTB Guinea pig 0.016 mg/ml* T Furuta/T Kaneko
PKCg Rabbit sc211 1:1,000 Santa Cruz Biotechnology
PKCg Guinea pig 1:500 M Watanabe
Calretinin Goat CG1 1:1,000 Swant
EGFP Chicken ab13970 1:1,000 Abcam
NeuN Mouse MAB377 1:500-1000 Millipore
*PPTB was detected with tyramide signal amplification.
4 Molecular Pain 0(0)
pre-incubation with 10 mg/ml neurotensin.31 Staining
with the rat antiserum against neurotensin in the rat
brain is identical to that seen with a well-characterised
rabbit antiserum and is blocked by pre-incubation with
104M neurotensin.56 The PPTB antibody was raised
against amino acids 95–116 of the rat PPTB48 and
detects PPTB (but not substance P, neurokinin A or
NKB) on dot blots. Immunostaining is abolished on
both dot blots and tissue sections by pre-incubation
with the peptide against which the antibody was
raised.48 The guinea pig antibody against PKCg was
raised against the C terminal 14 amino acids of the
mouse protein and recognises a single band of the appro-
priate molecular weight on Western blots of brain hom-
ogenates from wild-type, but not PKCg/ mice.57 The
rabbit PKCg antibody is directed against the C-terminus
of the mouse protein, and we have shown that it stains
identical structures to the guinea-pig PKCg antibody.52
The calretinin antibody was produced against human
recombinant calretinin and does not stain the brain of
calretinin knock-out mice (manufacturer’s specification).
The EGFP antibody was raised against recombinant full-
length EGFP, and its distribution matched that of the
EGFP. The mouse monoclonal antibody NeuN reacts
with a protein in cell nuclei extracted from mouse
brain,58 which has subsequently been identified as the
splicing factor Fox-3.59 NeuN apparently labels all neu-
rons but no glial cells in the rat spinal dorsal horn.60
Results
In all immunoreactions used throughout the study, anti-
body penetration appeared to be complete because
immunoreactive cells were found through the depth of
the section, and there was no obvious reduction in their
number in the middle of the sections.
Distribution and frequency of cells expressing
SST, neurotensin, PPTB or GRP-EGFP and their
coexpression with PKC
The distribution of cells that were immunoreactive for
each of these markers was similar to what has been
reported in previous studies in mouse and
rat.31,32,35,36,43,44,46,54,61–65 Quantitative results from this
part of the study are shown in Tables 2 and 3 and exam-
ples of immunostaining in Figures 1–3.
PKCg-immunoreactive neurons were concentrated in
laminae IIi and III, although scattered cells were seen
dorsal and ventral to this region (Figures 1–3).
Immunostaining was present in the somatic plasma mem-
brane and extended into dendrites, which formed a dense
plexus that occupied lamina IIi, as described previously.54
As in the rat,35 there was considerable variation in the
intensity of immunostaining between PKCg-immunor-
eactive cells. We estimated the proportion of neurons in
laminae I–II and in lamina III that were PKCg-immunor-
eactive by using the disector method in three sets of sec-
tions: those reacted with antibodies against SST,
neurotensin or PPTB in combination with NeuN, anti-
PKCg and DAPI staining. The total numbers of PKCg-
immunoreactive neurons identified in this part of the
study were 601 in laminae I–II and 183 in lamina III.
The results were highly consistent across the three sets
of sections: PKCg neurons corresponded to 21% of all
neurons in laminae I–II (range 20.4%–22.2%) and 13.9%
(12.7%–14.5%) of those in lamina III.
Immunostaining with the SST antibody formed a
dense band in laminae I–II, with scattered profiles in
lamina III (Figure 1). Immunoreactive cell bodies were
difficult to see at low magnification because of the very
high density of other profiles, which correspond mainly
to axonal boutons. However, they were readily visible at
Table 2. Proportions of neurons immunoreactive for neuropeptides or GRP-EGFP.
Laminae I–II Lamina III
Total number
of neurons
counted
Number of
IR neurons
% of neurons
that were IR
Estimated % of
excitatory
neurons that
were IR
Total number
of neurons
counted
Number of
IR neurons
% of neurons
that were IR
Estimated %
of excitatory
neurons that
were IR
SST 294 (259–333) 129 (112–152) 43.8 (42.4–45.6) 59 146.3 (144–150) 23.7 (20–27) 16.2 (13.8–18)
Neurotensin 304.3 (294–310) 20.3 (19–22) 6.7 (6.1–7.1) 9 144.3 (128–161) 11.3 (8–14) 7.8 (6.3–9.7) 12.5
PPTB 350 (335–374) 40.7 (33–47) 11.6 (9.9–12.6) 15.6 152 (134–174) 6.3 (4–8) 4.1 (3–4.7) 6.6
GRP–EGFP 616 (613–618) 68 (63–72) 11 (10.2–11.8) 14.8
The table shows the total number of neurons counted, together with the number and percentage that were immunoreactive (IR) for each peptide.
GRP-EGFP cells were rarely seen in lamina III and so were not counted in this lamina. In each case, the mean values for three mice are shown, with
the range in brackets. The estimates of percentage of excitatory neurons in each lamina that were accounted for by each neurochemical population are
based on the data from literature.73 Because an unknown proportion of SST cells in lamina III are inhibitory (GABAergic/glycinergic25,32), the proportion has
not been estimated for SST cells in lamina III.
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high magnification, with the SST-immunoreactivity
occupying part of the perikaryal cytoplasm, either sur-
rounding the nucleus or forming discrete clumps of stain-
ing that were asymmetrically distributed around the
nucleus (Figures 1d–f, 4a,f and 7c,f). This pattern pre-
sumably corresponded to staining within the Golgi
apparatus. The SST-immunoreactive neurons were par-
ticularly numerous and were most densely packed in the
superficial laminae, with a lower number being present in
lamina III. SST-immunoreactive cells accounted for 44%
of all neurons in laminae I–II and 16% of those in
lamina III (Table 2). Throughout laminae I–III, 34%
of SST-immunoreactive cells were also PKCg-immunor-
eactive, and these accounted for 63% of the PKCg cells
(Table 3).
Neurotensin immunoreactivity was less dense than
that seen for SST and showed a different laminar distri-
bution, being concentrated in lamina IIi where it over-
lapped the dense plexus of PKCg dendrites (Figure 2).
Again, cell bodies were difficult to identify at low
magnification but could readily be seen with oil-immer-
sion optics. Staining of cell bodies appeared as intense
granules that occupied part of the perikaryal cytoplasm
(Figures 2 and 4) and, in some cases, completely
surrounded the nucleus (Figure 6a). Neurotensin-immu-
noreactive cells were concentrated in the inner half of
lamina II and the dorsal part of lamina III. They
accounted for 7% of all neurons in laminae I–II and
8% of those in lamina III (Table 2). The great majority
of these cells (90%) were PKCg-immunoreactive, and
these accounted for 34% of the PKCg cells in laminae
I–III (Table 3).
As in the rat,35 the pattern of staining with the PPTB
antibody differed from that seen with the SST and neu-
rotensin antibodies, in that it was particularly prominent
in cell bodies, which could be seen at low magnification
(Figure 3a), and this is presumably because the antibody
is directed against the precursor peptide rather than the
mature neuropeptide.48 NKB-expressing (PPTB-immu-
noreactive) cells were also concentrated in the inner
half of lamina II, with some extension into lamina III.
Unlike what has been reported in the rat,35 we saw very
few PPTB-immunoreactive neurons in laminae I or IIo.
PPTBþ cells accounted for 12% of all neurons in laminae
I–II, and 4% of those in lamina III. The majority (58%)
of the PPTB cells were PKCg-immunoreactive, and these
accounted for 28% of the PKCg cells. However, as in the
rat,35 the intensity of PKCg immunoreactivity seen on
these PPTB cells was generally weak or moderate (Figure
3d–g).
As reported previously,36,44 GRP-EGFP cells were
mainly restricted to lamina II, and they accounted for
11% of the neurons in laminae I–II. Although scattered
GRP-EGFP cells are present in lamina III, we did not
quantify these.T
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Coexistence among neuropeptide populations
In sections reacted to reveal SST and the three other
peptide populations (neurotensin, PPTB, GRP-EGFP),
we found extensive co-localisation of SST with each of
the other markers (Figures 4 and 5, Table 4). In laminae
I–II, the majority (73%) of neurotensin-immunoreactive
cells were SST-immunoreactive (corresponding to 10%
of the SST-immunoreactive cells), although co-localisa-
tion was much less common in lamina III, with only 10%
of neurotensin cells showing SST immunoreactivity (cor-
responding to 3% of SST cells) (Figure 4, Table 4). A
majority (59%) of GRP-EGFPþ cells in laminae I–II in
these sections were also SST-immunoreactive (corres-
ponding to 15% of the SST population). However,
there was minimal overlap between neurotensin and
GRP-EGFP in these sections, with only 1.5% of GRP-
EGFP cells in laminae I–II showing neurotensin immu-
noreactivity, and 1.7% of neurotensin-immunoreactive
cells having EGFP. Most of the PPTB-immunoreactive
cells in laminae I–II (91%) showed SST immunoreactiv-
ity, corresponding to 21% of the SST cells, although
coexistence was less common in lamina III, where
55% of PPTBþ cells were SST-immunoreactive, cor-
responding to 25% of the SST population (Figure 5,
Table 4).
In sections reacted to reveal neurotensin and PPTB,
we found limited overlap between the two in laminae
I–II, with double-labelled cells corresponding to 13%
and 6% of the neurotensin and PPTB populations,
Figure 1 SST and PKCg immunoreactivity. (a–c) Immunostaining with antibodies against SST (green), PKCg (red), and NeuN (blue) in a
projection of 30 optical sections at 1mm z-spacing. The dashed line in (b) and (c) represents the lamina II-III border. SST immunoreactivity
occupies a dense band in laminae I–II, while PKCg cells are concentrated in the inner part of lamina II and lamina III. (d–g) show a higher
magnification view of a single optical section. Five SST-immunoreactive cells can be seen: four of these (arrowheads) are also PKCg-
immunoreactive, while one (arrow) is not. The inset shows a nearby cell that is PKCg-immunoreactive, but lacks SST. Scale bars: (a–
c)¼ 100 mm, (d–g)¼ 10 mm.
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respectively (Figure 6, Table 5). The extent of co-exis-
tence was higher in lamina III, corresponding to 34%
and 30% of neurotensin and PPTB cells, respectively.
In the sections that were immunostained for PPTB
and GRP-EGFP, no co-localisation was detected
(Figure 7).
Co-localisation of SST and calretinin
Although both SST and calretinin are expressed by large
numbers of excitatory interneurons in the superficial
dorsal horn, Duan et al.25 provided evidence to suggest
that they were present in non-overlapping populations.
However, we found extensive overlap between SST- and
calretinin-immunoreactivities in laminae I–II (Figure 8).
Themean numbers of SST- and calretinin-immunoreactive
cells identified in these sections were 178.3 (175–181) and
137.7 (126–161), respectively. Double-labelled cells
accounted for 52.7% (49.2%–55.9%) of the SST-immu-
noreactive cells and 67% (60.9%–70.6%) of the calreti-
nin-immunoreactive population.
Discussion
The main findings of this study are: (1) that immuno-
reactivity for SST, neurotensin, and PPTB are present in
44%, 7% and 10% of neurons in laminae I–II, respect-
ively, while 11% of neurons in this region are EGFPþ in
the GRP-EGFP mouse and (2) that while the neuroten-
sin, PPTB and GRP-EGFP populations are largely non-
overlapping, there is extensive co-localisation of SST
with each of these other markers.
Identification of peptidergic cell bodies with
immunocytochemistry
Although neuropeptides are synthesised and packaged in
the perikaryal cytoplasm of peptidergic neurons, they are
then transported to their axons, so that the concentra-
tion of neuropeptide in the cell body is often relatively
low. For some peptides (e.g. substance P), concentra-
tions in cell bodies are so low that they are undetectable
with immunocytochemistry. In many early studies,
Figure 2 Neurotensin and PKCg immunoreactivity. (a–c) Immunostaining with antibodies against neurotensin (NT, green) and PKCg
(magenta) in a projection of 18 optical sections at 1 mm z-spacing. The dashed line in (b) and (c) represents the lamina II-III border.
Neurotensin immunoreactivity forms a plexus in lamina IIi and III, which overlaps the distribution of PKCg immunostaining. (d-f) show a
higher magnification view of a projection of three optical sections. A neurotensin-immunoreactive cell that is also PKCg-immunoreactive is
indicated with an arrow, while the proximal dendrite of another neurotensin-immunoreactive PKCg cell can also be seen (arrowhead).
Scale bars: (a–c)¼ 100 mm, (d–f)¼ 10 mm.
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colchicine was administered to block axoplasmic trans-
port and increase somatic concentrations of peptides,21
but it was subsequently shown that colchicine could alter
mRNA levels for neuropeptides and potentially lead to
de novo expression.66,67 An alternative approach for
identifying peptidergic neurons would be to use in situ
hybridisation, but this is less easily combined with the
multiple-labelling strategies that are required for quanti-
fication and assessment of co-localisation. In the present
study, we identified NKB-expressing neurons with an
antibody against the precursor peptide (PPTB), which
was seen at high levels in cell bodies, with a distribution
closely matching that of PPTB mRNA,37,68,69 and it is,
therefore, likely that we detected most or all of the
NKB-expressing cells. With both neurotensin and SST
antibodies, we were able to detect many cells that had
immunoreactivity in the perikaryal cytoplasm, and in
each case, the distribution of cells closely matched that
reported with in situ hybridisation.37,38,70 However, since
we may have failed to detect cells with low levels of the
peptide in their cell bodies, our results should be con-
sidered as minimum estimates. Duan et al.25 reported
that the proportions of neurons with SST mRNA in
laminae I and II were 7% and 37%, respectively,
which is somewhat lower than our estimate that 44%
of neurons in laminae I–II were SST-immunoreactive:
this discrepancy may reflect greater sensitivity of the
immunocytochemical technique or differences in the
methods used for counting cells.
Although there are many neurons with GRP mRNA
in lamina II,12,28,38,44,46,71,72 antibodies against GRP fail
to detect these cells.36 We, therefore, used transgenic
mice, in which EGFP is expressed under control of the
GRP promoter.36,44,46 Solorzano44 reported that 93% of
EGFP cells in this mouse line were positive for GRP
mRNA, and that 68% of GRP mRNA-positive cells
had EGFP. They also suggested that the failure to
detect EGFP in some cells with GRP mRNA may have
been due to protease treatment during the in situ hybrid-
isation procedure. It is therefore likely that the great
majority (if not all) EGFPþ neurons express GRP, but
the use of EGFP as a surrogate marker may have
resulted in an underestimate of the size of the GRP
population.
Neurochemically defined subpopulations among the
excitatory interneurons in laminae I–II
We have reported that all SST-immunoreactive neurons
in rat superficial dorsal horn lacked GABA, although
some of those in laminae III–IV were GABA and/or
glycine enriched.32 We also showed that 98% of non-
primary afferent SST-immunoreactive boutons in lami-
nae I–II expressed the vesicular glutamate transporter 2
(VGLUT2.34 Xu et al.37,38 have found that SST
mRNAþ cells in the superficial laminae are eliminated
in mice lacking the transcription factors Tlx1/3, which
are required for the development of excitatory inter-
neurons in this region. Taken together, these results
suggest that all SST-expressing neurons in laminae I–
II are excitatory, although some of those in deeper
laminae are inhibitory. Similarly, in the rat, all
Figure 3 PPTB and PKCg immunoreactivity. (a–c) Immunostaining with antibodies against PPTB (green) and PKCg (magenta) in a
projection of 30 optical sections at 1 mm z-spacing. The dashed line in (b) and (c) represents the lamina II-III border. PPTB immunoreactivity
is present in numerous profiles in lamina IIi, which correspond to cell bodies. (d–g) show a higher magnification view of a single optical
section. Three PPTB-immunoreactive cells can be seen in this field, of which one (arrow) is weakly immunoreactive for PKCg and two
(arrowheads) are PKCg-negative. Scale bars: (a–c)¼ 100mm, (d–g)¼ 10 mm.
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Figure 4 SST, neurotensin, and EGFP immunoreactivity in a section from a GRP–EGFP mouse. (a–d) Immunostaining with antibodies
against SST (red), neurotensin (NT, blue), EGFP (green), and NeuN (grey) in a projection of three optical sections at 1 mm z-spacing shows
two EGFPþ cells (asterisks) that contain SST immunoreactivity (indicated with arrows). The arrowhead marks a neurotensin-expressing
neuron – the neurotensin immunoreactivity is seen as a cluster of blue puncta. The inset shows this cell in a projection of eight optical
sections, with neurotensin in green and NeuN in magenta. (e–g) Part of the same section scanned to reveal SST, neurotensin, and NeuN.
This image which is a projection of three optical sections at 1 mm z-spacing, includes three cells that are neurotensin-immunoreactive. Two
of these (arrows) are also SST-immunoreactive, while the third one (arrowhead) lacks SST. Scale bar¼ 10 mm.
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neurotensin-immunoreactive cell bodies in laminae II–
III lack GABA,31 while neurotensin axons (which are
thought to originate from local cells) are glutamate-
enriched,33 and 94% of these are VGLUT2-immunor-
eactive.34 PPTB-immunoreactive axons are also likely
to originate from local interneurons, and in the rat,
99% of these were VGLUT2-immunoreactive35 while
all cells in laminae II–III of the mouse with PPTB
mRNA were immunoreactive for Tlx3.37 Cells with
GRP mRNA in lamina II are absent in mice lacking
the transcription factors Gsx1/2 or Tlx3, in which
development of excitatory cells is disrupted,28,38 while
EGFPþ cells in the GRP-EGFP mouse lack Pax2 and
have axons that are immunoreactive for VGLUT2, but
not for the vesicular GABA transporter.36 Again, this
strongly suggests that expression of neurotensin, NKB
and GRP is restricted to excitatory neurons in this
region.
Figure 5 SST and PPTB immunoreactivity. (a–c) Immunostaining with antibodies against PPTB (red), SST (green), and NeuN (blue) in a
maximum intensity projection of three optical sections (1 mm z-spacing) from the lamina II/III border. (d) A merged image. Five
PPTB-immunoreactive cells are indicated. Four of these are also SST-immunoreactive (arrows), while the fifth (arrowhead) lacks SST.
Two neurons that are SST-immunoreactive but negative for PPTB are marked with asterisks. Scale bar¼ 10mm.
Table 4. Co-localisation of SST with other neuropeptide markers.
Laminae I–II Lamina III
Total number
of SST
neurons
examined
Total number
of other
neurons
examined
% SST
neurons
with other
marker
% other
marker
neurons
with SST
Total number
of SST
neurons
examined
Total number
of other
neurons
examined
% SST
neurons with
other marker
% other
marker
neurons
with SST
Neurotensin 171.7 (131–218) 56.3 (46–63) 9.5 (7.8–12.2) 73.4 (71.4–75) 30 (24–41) 20 (17–24) 3 (0–4.9) 10.4 (5.3–17.6)
GRP-EGFP 171.7 (131–218) 107.3 (91–121) 15.4 (13.3–16.8) 59 (51.6–65.3)
PPTB 140 (119–156) 88.3 (83–95) 20.6 (17.2–24.4) 90.5 (87.4–92.6) 22.7 (18–28) 23.7 (21–27) 25.4 (16.7–32.1) 54.5 (47.6–59.3)
The second and third columns show the total numbers of neurons examined in laminae I–II that were either SST-immunoreactive or immunoreactive for the
other marker, respectively. The corresponding values for lamina III are shown in the sixth and seventh columns. Note that, as described in the Methods
section a relatively narrow disector (10 mm) was initially used to sample SST-immunoreactive neurons and test the proportion with the other marker. A
wider disector (between 18 and 30 mm) was then used to sample neurons with the other type of immunoreactivity and test them for the presence of SST-
immunoreactivity. This was done because the number of SST-immunoreactive neurons was far larger than the number of cells immunoreactive for each of
the other markers. In each case, the mean values for three mice are shown, with the range in brackets.
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We have previously reported that neurons lacking
GABA- and glycine-immunoreactivity account for
74.2% and 62.4% of the total neuronal population in
laminae I–II and lamina III, respectively.73 Since these
cells are all likely to be glutamatergic,14 this allows us to
estimate the proportions of excitatory neurons in these
regions that express SST, neurotensin, PPTB or GRP-
EGFP. In laminae I–II, cells belonging to each of these
neuropeptide populations should account for 59%, 9%,
13.6% and 14.8% of the glutamatergic neurons, respect-
ively (Table 2). We can also estimate that neurotensin-
and PPTB-expressing cells would account for 12.5% and
6.6% of excitatory interneurons in lamina III, respect-
ively. However, since SSTþ cells in lamina III include an
unknown proportion of inhibitory interneurons,25,32 it is
not possible to determine the percentage of excitatory
neurons in this lamina that are SST-immunoreactive.
The present findings are generally consistent with
what has been reported in the rat, for example, in both
species, SST is expressed by numerous cells and overlaps
extensively with PPTBþ neurons, while the majority of
both neurotensin and PPTB cells express PKCg.35,43
However, there are some differences, including a limited
overlap between neurotensin and PPTB populations and
the expression of SST in most neurotensin cells in the
mouse, neither of which were seen in the rat.32,35 In add-
ition, there are many PPTB-immunoreactive neurons in
lamina I-IIo in the rat,35 and these are not detected in the
Figure 6 Neurotensin and PPTB immunoreactivity. (a–c) Immunostaining with antibodies against neurotensin (NT, green), PPTB (red),
and NeuN (blue) in a single optical section at the lamina II/III border. (d) A merged image. Two neurotensin–immunoreactive cells (arrows)
and two PPTB-immunoreactive cells (arrowheads) are indicated. In each case, the cells are negative for the other marker. Scale
bar¼ 10mm.
Table 5 Co-localisation of neurotensin (NT) with PPTB.
Laminae I–II Lamina III
Total NT
neurons
counted
Total PPTB
neurons
counted
% NT
neurons
with PPTB
% PPTB
neurons
with NT
Total NT
neurons
counted
Total PPTB
neurons
counted
% NT
neurons
with PPTB
% PPTB
neurons
with NT
47 (38–52) 103 (98–109) 12.6 (10.5–15.7) 5.7 (4.1–7.3) 23 (15–27) 25.3 (24–27) 33.8 (33.3–34.6) 30.1 (20.8–36)
The first and second columns show the total numbers of neurons examined in laminae I–II that were either NT-immunoreactive or PPTB-immunoreactive,
while the corresponding values for lamina III are shown in the fifth and sixth columns. In each case, the mean values for three mice are shown, with the range
in brackets.
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mouse either with immunocytochemistry or with in situ
hybridisation,69,70 which suggests that this is a species
difference.
The limited overlap among the neurotensin, PPTB
and GRP populations allows us to estimate that between
them, they account for 37% of the excitatory inter-
neurons in laminae I–II. This is illustrated in Figure 9,
which also reveals the extent to which each of these
populations (together with excitatory neurons that lack
neurotensin, NKB or GRP-EGFP) express SST.
Cholecystokinin is expressed by neurons in lamina III
that are derived from a Tlx3þ population,37 and they are
also dependent on Gsx1/2,28 suggesting that these cells
are exclusively excitatory interneurons. It will, therefore,
be of interest to know whether they overlap with either
neurotensin or PPTB populations in this lamina.
Substance P-expressing cells can be identified by the
presence of Tac1 mRNA, and Xu et al.38 identified a
Tlx3-dependent population of these cells in laminae
I–II. We have reported that substance P, NKB and
EGFP are not co-localised in axonal boutons in the
GRP-EGFP mouse,36 and we have also found no co-
localisation of neurotensin with substance P in the
mouse superficial dorsal horn (MGM and AJT, unpub-
lished observations). This suggests that the substance
P-expressing cells correspond to an additional popula-
tion that does not overlap with those that express neu-
rotensin, NKB or GRP.
Functional roles of neurochemically defined excitatory
interneuron populations
Various roles have been attributed to excitatory inter-
neurons in the superficial laminae. Mice lacking PKCg
show reduced neuropathic pain,64 and it has been sug-
gested that the PKCg-expressing cells in laminae IIi–III
provide a route through which tactile inputs can gain
access to nociceptive projection neurons in lamina I.45
Our results indicate that both NKB and neurotensin
are expressed by PKCg neurons in this region, account-
ing for around a quarter and a third of the PKCg cells,
respectively. Duan et al.25 reported that ablation of the
NKB population had no effect on nerve-injury induced
tactile allodynia. This could be because PKCg cells that
are required for the development of tactile allodynia
are those that lack NKB, or alternatively because it is
necessary to lose a high proportion of the PKCg cells
before this affects neuropathic pain. A further complica-
tion is that there may be a mismatch between cells that
are targeted in ablation studies25 and those with detect-
able levels of the corresponding neuropeptide. For exam-
ple, this could result from a very low level of peptide
expression in some neurons, the presence of cells that
fail to translate the corresponding mRNA, and/or
incomplete loss of cells that express the toxin-encoding
transgene.
The present findings indicate that SST is expressed in
the majority of excitatory neurons in the superficial lami-
nae, including most of those belonging to the other pep-
tidergic populations (Figure 9). Consistent with this,
Duan et al.25 reported that Cre-expressing cells in a
SSTCre knock-in mouse were physiologically and mor-
phologically heterogeneous. SST-expressing excitatory
neurons are, therefore, very unlikely to correspond
to a single functional population, and the finding that
their ablation disrupted mechanical pain is perhaps not
surprising, since this is likely to have resulted in loss of a
large and diverse set of excitatory interneurons.
Figure 7 PPTB and EGFP immunoreactivity in a section from a
GRP-EGFP mouse. (a,b) Immunostaining for EGFP (green) and
PPTB (magenta) in a maximum intensity projection of 27 optical
sections at 1 mm z-spacing. (c) A merged image. Numerous cells
that are either EGFP-immunoreactive or PPTB-immunoreactive
are present in this field, but none of them is double-labelled. Scale
bar¼ 20mm.
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However, Duan et al.25 reported that ablating calreti-
nin-expressing cells caused only a loss of sensation of
light punctate mechanical stimuli. Based on their failure
to detect SST mRNA in Creþ neurons in a calretininCre
knock-in mouse, they concluded that SST and calretinin
were present in separate populations in laminae I–II and
that SST cells were required for detecting mechanical
pain, whereas calretinin neurons mediated light punctate
sensation. However, our finding that over half of the
SST-immunoreactive cells contained calretinin, and
that two thirds of calretinin cells contained SST indicate
that the SST and calretinin populations are not mutually
exclusive. An alternative explanation for the behavioural
differences seen after ablation of SST and calretinin cells
is that a significant proportion of the calretinin popula-
tion consists of inhibitory interneurons. A recent study
has shown that 12% of calretinin-immunoreactive cells
in laminae I–II of the mouse express Pax2 and are, there-
fore, presumably inhibitory.42 Further evidence for this
was that EGFP-labelled cells in a calretinin-EGFP
mouse included typical islet cells, which are invariably
inhibitory.14,15,45,74–76 It is, therefore, possible that by
ablating calretinin cells, Duan et al.25 lost both excita-
tory interneurons (which overlap extensively with the
SST population) and also a set of GABAergic (inhibi-
tory) islet cells. If the latter have a role in inhibiting
mechanical pain, then their loss could have partially
compensated for the reduction in excitatory
transmission.
Interestingly, Duan et al.25 found that although mech-
anical pain was dramatically reduced following ablation
of the SST cells, thermal pain was unaffected.
Figure 8 Calretinin and SST immunoreactivity. (a–c) Immunostaining for calretinin (CR, green) and SST (red) in a single optical section
through lamina II. (d) A merged image, which also shows staining for NeuN (blue). Several calretinin-immunoreactive cell bodies are
present in the section, and three of these are marked with arrows. Each of these cells show SST-immunoreactivity. The two calretinin-
labelled profiles indicated with arrowheads are proximal dendrites of lamina II neurons, and both of these are also SST-immunoreactive.
The asterisk marks a SST-immunoreactive neuron that lacks calretinin. Scale bar¼ 10mm.
Figure 9 Proportions of excitatory neurons in laminae I–II that
belong to different neurochemical populations. The pie chart
shows the proportions of all excitatory interneurons in laminae I–II
that are accounted for by each neurochemical population. Note
that there is no overlap between GRP-EGFP and NKB-expressing
(PPTB-immunoreactive) populations, but a minimal overlap
between each of these and the neurotensin population. In contrast,
SST is expressed by the majority (59%–91%) of cells in each of the
other peptide populations, as well as by many (49%) of those that
lack these other peptides.
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Mechanical pain perception in the mouse is thought to
depend on non-peptidergic unmyelinated primary affer-
ents that express the Mas-related protein Mrgd, whereas
thermal pain requires TRPV1þ primary afferents, which
largely correspond to those that express neuropep-
tides.77,78 The C-Mrgd afferents terminate in the middle
part of lamina II and do not provide direct synaptic
input to nociceptive projection neurons in laminae I or
III.79 In contrast, peptidergic nociceptors directly innerv-
ate projection neurons in both laminae I and III,80,81 and
we have estimated that these afferents provide
around half of the excitatory synapses on the neurokinin
1 receptor-expressing lamina I projection cells.82 It is,
therefore, likely that much of the thermal nociceptive
input reaches projection neurons directly, whereas the
noxious mechanical input is relayed through excitatory
interneurons in lamina II that constitute part of the SST
population.
Conclusions
These results suggest that cells expressing neurotensin,
NKB or GRP form largely non-overlapping popula-
tions, which account for 40% of the excitatory inter-
neurons in laminae I–II, and these populations are,
therefore, likely to be functionally distinct. In contrast,
SST is expressed by 60% of excitatory interneurons in
the superficial laminae, and the SST cells are presumably
functionally heterogeneous.
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